{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:17:19Z","timestamp":1781083039628,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/rlu.0000000000001100","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T13:34:30Z","timestamp":1450272870000},"page":"e281-e287","source":"Crossref","is-referenced-by-count":37,"title":["Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors"],"prefix":"10.1097","volume":"41","author":[{"given":"Farshad","family":"Moradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Barkhodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-32-20210204","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/erc.0.0100451","article-title":"Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours","volume":"10","author":"de Herder","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"R2-32-20210204","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","article-title":"Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin","volume":"1","author":"Krenning","year":"1989","journal-title":"Lancet"},{"key":"R3-32-20210204","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-32-20210204","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1754-9485.2011.02327.x","article-title":"High management impact of Ga-68 DOTATATE (GaTate) PET\/CT for imaging neuroendocrine and other somatostatin expressing tumours","volume":"56","author":"Hofman","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"key":"R5-32-20210204","first-page":"426","article-title":"The value of (68)Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R6-32-20210204","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jamcollsurg.2015.04.005","article-title":"Results of (68)Gallium-DOTATATE PET\/CT scanning in patients with multiple endocrine neoplasia type 1","volume":"221","author":"Sadowski","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R7-32-20210204","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy","volume":"51","author":"Srirajaskanthan","year":"2010","journal-title":"J Nucl Med"},{"key":"R8-32-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1245\/s10434-014-3981-2","article-title":"Impact of (68)Ga-DOTATATE PET\/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum","volume":"22","author":"Ilhan","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R9-32-20210204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.114.148247","article-title":"Impact of 68Ga-DOTATATE PET\/CT on the management of neuroendocrine tumors: the referring physician's perspective","volume":"56","author":"Herrmann","year":"2015","journal-title":"J Nucl Med"},{"key":"R10-32-20210204","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"key":"R11-32-20210204","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/MNM.0b013e32833f635e","article-title":"Distribution pattern of 68Ga-DOTATATE in disease-free patients","volume":"31","author":"Shastry","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R12-32-20210204","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/RLU.0b013e31825b2555","article-title":"Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET\/CT","volume":"37","author":"Kunikowska","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R13-32-20210204","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00259-011-1937-3","article-title":"The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy","volume":"39","author":"Beauregard","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-32-20210204","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s00259-012-2309-3","article-title":"68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET\/CT","volume":"40","author":"Kroiss","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-32-20210204","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"68Ga-DOTATOC versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","author":"Poeppel","year":"2011","journal-title":"J Nucl Med"},{"key":"R16-32-20210204","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/000348947308200403","article-title":"Surgery for acoustic neurinoma","volume":"82","author":"Montgomery","year":"1973","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R17-32-20210204","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2967\/jnumed.113.126177","article-title":"Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification","volume":"55","author":"Velikyan","year":"2014","journal-title":"J Nucl Med"},{"key":"R18-32-20210204","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12149-014-0856-3","article-title":"68Ga-DOTATATE PET\/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin","volume":"28","author":"Alonso","year":"2014","journal-title":"Ann Nucl Med"},{"key":"R19-32-20210204","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/RLU.0000000000000863","article-title":"Intrapancreatic accessory spleen mimicking neuroendocrine tumor on 68Ga-DOTATATE PET\/CT","volume":"40","author":"Bhure","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R20-32-20210204","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/RLU.0000000000000412","article-title":"Somatostatin receptor-positive granulomatous inflammation mimicking as meningioma on simultaneous PET\/MRI","volume":"40","author":"Taneja","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R21-32-20210204","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/RLU.0000000000000807","article-title":"Talc pleurodesis with intense 18 F-FDG activity but no 68Ga-DOTA-TATE activity on PET\/CT","volume":"40","author":"Papadakis","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R22-32-20210204","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2967\/jnumed.108.053421","article-title":"68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy","volume":"50","author":"Gabriel","year":"2009","journal-title":"J Nucl Med"},{"key":"R23-32-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2014.00009","article-title":"Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography","volume":"13","author":"Koch","year":"2014","journal-title":"Mol Imaging"},{"key":"R24-32-20210204","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2967\/jnumed.110.075002","article-title":"68Ga-DOTATATE PET\/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors","volume":"51","author":"Haug","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:14:19Z","timestamp":1620972859000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201606000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001100","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}